recording efficacy of l-arginine in improving outcomes in patients with oligohydramnios
Not Applicable
- Conditions
- Health Condition 1: O998- Other specified diseases and conditions complicating pregnancy, childbirth and the puerperium
- Registration Number
- CTRI/2024/04/065276
- Lead Sponsor
- none
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
having oligohydramnios and prescribed arginine, singleton pregnancies, oligohydramnios without arginine
Exclusion Criteria
multiple pregnancy, PPROM, congenital anomaly, those who dont consent to take part
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method increase in gestational age, increase in AFITimepoint: increase in gestational age, increase in AFI
- Secondary Outcome Measures
Name Time Method mode of deliveryTimepoint: 1.5 to 2 years